Immunoaffinity CE in clinical analysis of body fluids and tissues.
This paper reviews immunoaffinity CE procedures developed since 1998 for drug, hormone, and disease marker analyses of body fluids and tissues. Immunoaffinity CE and related techniques are described. Examples of clinical applications are included.
Amundsen
Lotta K
LK
Technical Research Centre of Finland (VTT), P.O. Box 1000, FIN-02044 VTT, Finland.
Sirén
Heli
H
D000906:Antibodies; D015415:Biomarkers / Q000032:analysis*; D001826:Body Fluids / Q000737:chemistry*; D019075:Electrophoresis, Capillary / Q000379:methods*; D006728:Hormones / Q000032:analysis; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007128:Immunoglobulin Fragments; D046210:Microfluidic Analytical Techniques; D008904:Miniaturization; D004364:Pharmaceutical Preparations / Q000032:analysis
D000906:Antibodies; D015415:Biomarkers; D006728:Hormones; D007128:Immunoglobulin Fragments; D004364:Pharmaceutical Preparations